Addiction Medicine and Addiction Psychiatry Fellows have opportunities to develop research projects in their identified areas of interest with the goal of gaining in-depth knowledge, preparing presentations, and presenting posters and manuscripts.   

Fellows with a particular interest in community-based research have the opportunity to participate in longitudinal electives in the Department of Family and Community Medicine’s Program for Supportive Healthcare.
The mission of the Program for Supportive Healthcare at Jefferson is to improve healthcare in partnership with people experiencing serious mental illnesses (SMI) and substance use disorders (SUD). Our focus is on developing and testing new models of care and educating healthcare professionals to deliver better healthcare and to improve health and well-being. 

Fellows can also partner with post-doctoral fellows in the HRSA T32 Jefferson Mental Illness, Addiction, & Primary Care (JeffMAP) Fellowship. This collaborative, multi-department and interdisciplinary training program will prepare 10 exceptional post-doctoral trainees to cultivate research projects in areas of urgent need in our region and nationally. The program focuses on addressing the closely interrelated priorities of ending the crisis of opioid use disorders and improving mental health access and care in integrated primary care and behavioral health settings. 
There are multiple opportunties for Addiction Medicine and Addiction Psychiatry fellows to collaborate with JeffMAP fellows’ on core HRSA T32 Research Initiatives, including:

• Integrated primary and behavioral health care within supportive housing for people with SMI and/or SUD
• Low-barrier primary care and treatment for people with opioid use disorders
• Harm reduction and drug-checking for people who use drugs (PWUD)
• Peer navigation
• Supporting caregivers
• Stakeholder identified definitions of recovery
• Community integration and social networks
• Improvement of medical education to address care of vulnerable populations
• Racial disparities in OUD treatment access and utilization in Philadelphia